- Transcription factor T-bet is a diagnostic marker for necrotizing enterocolitis development in premature newborns
 
Transcription factor T-bet is a diagnostic marker for necrotizing enterocolitis development in premature newborns
	Modern Pediatrics. Ukraine. (2022). 8(128): 6-11. doi 10.15574/SP.2022.128.6
	Abaturov O. E.1, Tovarnytska A. O.2
	1Dnipro State Medical University, Ukraine
	2LLC «Dnipro Medical Institute of Traditional and Non-traditional Medicine», Ukraine
	For citation: Abaturov OE, Tovarnytska AO. (2022). Transcription factor T-bet is a diagnostic marker for necrotizing enterocolitis development in premature newborns. Modern Pediatrics. Ukraine. 8(128): 6-11. doi 10.15574/SP.2022.128.6.
	Article received: Oct 07, 2022. Accepted for publication: Dec 19, 2022.
	Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease that mainly affects preterm infants. The non-specificity of the clinical picture and the high percentage of complications determine the need for early diagnosis and prevention of the disease.
	Purpose – to establish a relationship between the T-bet expression level in the cells of the buccal mucosa, the development of HEC and the method of feeding in premature newborn infants.
	Materials and methods. We examined 74 newborns, who were treated in neonatal departments. We selected three groups for comparison: the Group 1 consisted of 32 newborns up to 37 weeks of gestation on breastfeeding (BF); the Group 2 – 30 preterm newborns on artificial feeding (AF); the control group – 12 full-term newborns on BF. We determined the expression level of T-bet transcription gene factor in the cells of the buccal mucosa scrapings of the newborns. Thereafter, we have calculated the T-bet normalized expression levels in the cells of the mucous membranes of infants of the Group 1 and the Group 2 in relation to the control group, where the expression level of the specified factors was taken as 1 c.u.
	Results. The gestational age median of the Group 1 children was 33 (31; 34) weeks; the Group 2 – 32.5 (32; 35) weeks; and it was comparatively higher versus in the Group 1 (p<0.001) – 40 (39; 41) weeks. NEC has significantly more often developed in premature children on AF than on BF (p<0.05) – 30.0±8.4% versus 9.4±5.2%. The T-bet expression in the cells of the buccal mucosa scrapings was higher in preterm children, and the highest level was in the Group 2 – 2.4 (1.98; 3.84) c.u. versus 1.48 (1.13; 2.22) c.u. in the Group 1. We have proved a direct relationship between AF and T-bet level (r=0.370; p<0.004). Pairwise comparison revealed a higher level of T-bet in children with NEC (p=0.002): 2.36 (1.94; 3.17) c.u versus 1.74 (1.01; 3.27) c.u. without signs of NEC. We found a direct correlation between the T-bet level and the development of HEC (r=0,271; p=0.021).
	Conclusions. The T-bet expression level in the cells of the buccal mucosa increases in newborns with the appearance of the clinical signs of NEC. The level of T-bet expression in the buccal mucosa cells can be a marker of the inflammatory process development in intestine of infants. The expression of T-bet in the buccal mucosa cells of newborns with clinical signs of NEC is higher than in full-term newborns that reflects the tendency to NEC development. We have demonstrated that the T-bet expression level is higher in preterm neonates on AF. Therefore, AF can be considered as a risk factor for the development of NEC in preterm infants.
	The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies.
	No conflict of interests was declared by the authors.
	Keywords: T-bet, preterm infants, premature, necrotizing enterocolitis, NEC, artificial feeding.
	REFERENCES
1. Alganabi M, Lee C, Bindi E et al. (2019, Jan 25). Recent advances in understanding necrotizing enterocolitis. F1000Res. 8: F1000 Faculty Rev-107. https://doi.org/10.12688/f1000research.17228.1; PMid:30740215 PMCid:PMC6348433
2. Bazacliu C, Neu J. (2019). Necrotizing Enterocolitis: Long Term Complications. Curr Pediatr Rev. 15 (2): 115-124. https://doi.org/10.2174/1573396315666190312093119; PMid:30864508
3. Bellodas SJ, Kadrofske M. (2019, Mar). Necrotizing enterocolitis. Neurogastroenterol Motil. 31 (3): e13569. https://doi.org/10.1111/nmo.13569; PMid:30793842
4. Berken JA, Chang J. (2022). Neurologic Consequences of Neonatal Necrotizing Enterocolitis. Dev Neurosci. 44 (4-5): 295-308. Epub 2022 Jun 13. https://doi.org/10.1159/000525378; PMid:35697005
5. Cho SX, Berger PJ, Nold-Petry CA, Nold MF. (2016, Jun 24). The immunological landscape in necrotising enterocolitis. Expert Rev Mol Med. 18: e12. https://doi.org/10.1017/erm.2016.13; PMid:27341512 PMCid:PMC5001507
6. Cho SX, Rudloff I, Lao JC et al. (2020, Nov 13). Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities. Nat Commun. 11 (1): 5794. https://doi.org/10.1038/s41467-020-19400-w; PMid:33188181 PMCid:PMC7666196
7. Cobb BA, Carlo WA, Ambalavanan N. (2004, Jan). Gastric residuals and their relationship to necrotizing enterocolitis in very low birth weight infants. Pediatrics. 113 (1 Pt 1): 50-53. https://doi.org/10.1542/peds.113.1.50; PMid:14702446
8. Di Giovangiulio M, Rizzo A, Franzè E, Caprioli F, Facciotti F, Onali S et al. (2019, Sep 11). T-bet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis. Front Immunol. 10: 2158. https://doi.org/10.3389/fimmu.2019.02158; PMid:31572375 PMCid:PMC6749075
9. Gregory KE. (2008, Jul-Aug). Clinical predictors of necrotizing enterocolitis in premature infants. Nurs Res. 57 (4): 260-270. https://doi.org/10.1097/01.NNR.0000313488.72035.a9; PMid:18641495
10. Gunasekaran A, Devette C, Levin S, Chaaban H. (2022, Mar). Biomarkers of Necrotizing Enterocolitis: The Search Continues. Clin Perinatol. 49 (1): 181-194. Epub 2022 Jan 21. https://doi.org/10.1016/j.clp.2021.11.011; PMid:35210000
11. Huang C, Bi J. (2021, Oct 5). Expression Regulation and Function of T-Bet in NK Cells. Front Immunol. 12: 761920. https://doi.org/10.3389/fimmu.2021.761920; PMid:34675939 PMCid:PMC8524037
12. Kachler K, Holzinger C, Trufa DI, Sirbu H, Finotto S. (2018, Apr 25). The role of Foxp3 and T-bet co-expressing Treg cells in lung carcinoma. Oncoimmunology. 7 (8): e1456612. https://doi.org/10.1080/2162402X.2018.1456612; PMid:30221050 PMCid:PMC6136856
13. Kallies A, Good-Jacobson KL. (2017, Apr). Transcription Factor T-bet Orchestrates Lineage Development and Function in the Immune System. Trends Immunol. 38 (4): 287-297. Epub 2017 Mar 7. https://doi.org/10.1016/j.it.2017.02.003; PMid:28279590
14. KIM JH. (2022, Oct). Neonatal necrotizing enterocolitis: Clinical features and diagnosis. UpToDate®. URL: https://www.uptodate.com/contents/neonatal-necrotizing-enterocolitis-clinical-features-and-diagnosis/print?search=necrotizing%20enterocolitis&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2.
15. Knox JJ, Myles A, Cancro MP. (2019, Mar). T-bet+ memory B cells: Generation, function, and fate. Immunol Rev. 288 (1): 149-160. https://doi.org/10.1111/imr.12736; PMid:30874358 PMCid:PMC6626622
16. Lazarevic V, Glimcher LH. (2011, Jun 20). T-bet in disease. Nat Immunol. 12 (7): 597-606. https://doi.org/10.1038/ni.2059; PMid:21685955 PMCid:PMC6290474
17. Lazarevic V, Glimcher LH, Lord GM. (2013, Nov). T-bet: a bridge between innate and adaptive immunity. Nat Rev Immunol. 13 (11): 777-789. Epub 2013 Oct 11. https://doi.org/10.1038/nri3536; PMid:24113868 PMCid:PMC6290922
18. Li YF; Lin HC; Torrazza RM et al. (2014). Gastric Residual Evaluation in Preterm Neonates: A Useful Monitoring Technique or a Hindrance? Pediatrics & Neonatology. 55 (5): 335-340. https://doi.org/10.1016/j.pedneo.2014.02.008; PMid:25129325
19. Managlia E, Yan X, De Plaen IG. (2022, Jan-Mar). Intestinal Epithelial Barrier Function and Necrotizing Enterocolitis. Newborn (Clarksville). 1 (1): 32-43. Epub 2022 Mar 31. https://doi.org/10.5005/jp-journals-11002-0003; PMid:35846894 PMCid:PMC9286028
20. Meister AL, Doheny KK, Travagli RA. (2020, Jan). Necrotizing enterocolitis: It's not all in the gut. Exp Biol Med (Maywood). 245 (2): 85-95. Epub 2019 Dec 6. https://doi.org/10.1177/1535370219891971; PMid:31810384 PMCid:PMC7016421
21. Ministry of Health of Ukraine. (2022). Necrotizing Enterocolitis in Premature Children. Evidence-Based Guideline. URL: https://www.dec.gov.ua/wp-content/uploads/2022/01/2022_182_kn_nekrenter.pdf
22. Mϋller MJ, Paul T, Seeliger S. (2016, Sep 16). Necrotizing enterocolitis in premature infants and newborns. J Neonatal Perinatal Med. 9 (3): 233-242. https://doi.org/10.3233/NPM-16915130; PMid:27589549
23. Neu J. (2020). Necrotizing Enterocolitis: The Future. Neonatology. 117 (2): 240-244. Epub 2020 Mar 10. https://doi.org/10.1159/000506866; PMid:32155645
24. Rich BS, Dolgin SE. (2017, Dec). Necrotizing Enterocolitis. Pediatr Rev. 38 (12): 552-559. https://doi.org/10.1542/pir.2017-0002; PMid:29196510
      
 
 
 
 
 
 